Clinical Trials Market: By Clinical Trial Phase (Phase 0, Phase 1, Phase 2, Phase 3, Phase 4), By Disease Type (Infectious diseases, Cancer, Diabetes, Autoimmune disorders, Inflammatory diseases, Cardiovascular diseases, Haematological disorders, Neurological disorders, Dermatology, Others), By Design (Observational trials, Interventional trials, Expanded access trials), By End user (Clinical research organizations, Pharmaceutical and biotechnology companies, Research institutes, Others) and Geography  

Clinical Trials Market size was valued at USD 46.8 billion in the year 2023 and is anticipated to grow USD 70.23 Bn by 2030 at a CAGR of 7.5% from 2024-2030. Clinical trials are research studies primarily performed on humans to get data about the safety and efficacy of newer biomedical interventions including novel devices, vaccines, drugs, and treatments. Generally, clinical trials are regulated by the ethics committees and health authorities. On the broad base, clinical trials are carried out to determine the overall pharmacokinetic and pharmacodynamic properties of the products. Clinical trials are carried out under various phases such as Phase 0 to Phase 3 and Phase 4 is carried out for a post-marketing study of the products. The product will be recalled if it fails at any stage of the clinical trial. Geographically, the Clinical Trials market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. for the development of capabilities in infectious diseases and vaccines. Clinical trials are research investigations in which people volunteer to test medical equipment or pharmaceuticals to figure out how to cure particular diseases or problems. They are carried out to diagnose, detect, and prevent certain diseases. To carry out the testing method, each clinical trial has its own set of protocols and action plans. Clinical trials are used to gather information about the efficacy, safety, and efficacy of pharmaceuticals and medical treatments on animals and humans.

Clinical Trials Market Key Developments:

• In June 2017, Audax private equity acquired the Altasciences Clinical Researches for organizing the clinical trials.
• In September 2016, Icon Plc has acquired Clinical Research Management, Inc